US Capitol Capsule: No sign FDA chief sought stronger powers before meningitis crisis
This article was originally published in Scrip
Executive Summary
Since reports first emerged about infections caused by medicines contaminated with fungus and bacteria compounded by a Massachusetts pharmacy – with more than 400 Americans sickened by the tainted drugs so far – the US FDA has emphasized it lacks authority to properly regulate those entities and insisted regulators are working to prevent a similar catastrophe in the future.